RFP QuestBeta
ClosedStage · preprocurement

NHS England

Identification and Referral Service of VHRW Following Radiotherapy

IT ServicesCPV 72000000 48000000 48800000 48810000 48814000
ValueValue not published
Deadline4 Dec 2024
Published13 Nov 2024
RegionLondon
Timeline
Published 13 Nov 2024ClosedCloses 4 Dec 2024
Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

NHS England is to conduct market engagement to obtain input and feedback in preparation for a potential Identification and Referral Service of Very High Risk Women Following Radiotherapy.

The VHR cohort are currently identified and referred into the NHS Breast Screening Programme via clinical genetics services, clinical oncologists, and the service commissioned by NHS England from the Breast screening After Radiotherapy Dataset Group (BARD).

Patients cured of a first cancer at a young age are at an increased risk of developing a second primary breast cancer.

This is demonstrated in female survivors of Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL) who received radiotherapy to breast tissue under the age of 36 and whose subsequent risk of breast cancer is raised.

There will be a small number of women who have received radiotherapy to breast tissue as part of a treatment plan for diagnoses other than lymphoma.

Current national guidelines recommend that screening should start 8 years after radiotherapy to breast tissue or at age 25 or 30 (depending on circumstances), whichever occurs later.

In 2022/23, 10,493 women were screened within the NHSBSP VHR pathway.

Key requirements

What the supplier must deliver

01

This is demonstrated in female survivors

This is demonstrated in female survivors of Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL) who received radiotherapy to breast tissue under the age of 36 and whose subsequent risk of breast cancer is raised.

02

Current national guidelines recommend that screening should

Current national guidelines recommend that screening should start 8 years after radiotherapy to breast tissue or at age 25 or 30 (depending on circumstances), whichever occurs later.

Derived from the notice text — always confirm against the original documents.

Buyer intelligence

Make the case to bid

Reveal who to approach at NHS England, and generate a go-to-market strategy from their news, accounts and people.

Deep dive · beta

The full intelligence dossier

Our agent reads NHS England’s accounts, hunts live signals, finds the people who decide — and hands you a bid strategy plus a go-to-market influence plan, including what your team should post this week. You approve every paid step.

Source & provenance
OCID
6b267eae-e344-48b1-a86b-ae35efb7eb37
Stage
preprocurement · Closed
Source
Contracts Finder
Buyer ref
CF-2705700D0O000000rwimUAA
View the original notice on Contracts Finder

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in IT Services

Scroll to explore the market network

NHS England’s tender network

Assembling the network…

Also open now

Similar open tenders

NHS England - Dynamic Purchasing System for the Provision of Lloyd George Record Digitialisation Services

NHS England

Closes 1 Aug 2026Business Services
£90.0mValue

IT Managed Services

Caledonian Maritime Assets Ltd (Utility)

Closes 24 Aug 2026Communications Equipment
Value not publishedValue